首页> 中文期刊> 《现代检验医学杂志》 >孕产妇及其新生儿的 HBV 检测结果相关性分析

孕产妇及其新生儿的 HBV 检测结果相关性分析

         

摘要

Objective To investigate the risk factors of intrauterine hepatitis B virus (HBV)infection and its preventive measures.Methods 254 cases of pregnant women with positive HBsAg and their neonatuses from Shaanxi People’s Hospi-tal were selected as the research object.The serum of pregnant women were tested HBV markers and HBV-DNA,their neo-natal umbilical cord blood were only detected HBV markers.Results In 254 samples,the positive rates of HBsAg and HBeAg within their neonatal umbilical cord blood were 5.12% and 13.78% respectively;the positive rate of HBV infection in neonatal umbilical cord blood among maternal HBeAg-positive group was 53.33%,far higher than 3.61% in HBeAg-neg-ative group (χ2 =99.44,P <0.001);the positive rates of HBsAg and HBeAg in neonatal umbilical cord blood were elevated along with the increase of maternal HBV-DNA copy (Hc= 13.50,66.70;P < 0.001).The positive rate of HBV-DNA in pregnant women with HBeAg-positive group was 100%,far more than 19.59% in HBeAg-negative group (P <0.001).Con-clusion Both maternal positive HBeAg and HBV-DNA are risk factors for neonatal intrauterine HBV infection.Prenatal HBeAg screening is predominant,especially in some hospitals without real-time quantitative assay.An effective measure to reduce intrauterine HBV infection is to be pregnant when HBV DNA and HBeAg are turned into negative after HBV inter-vention and treatment for women in reproductive age.%目的:通过对 HBsAg 阳性孕产妇及其新生儿的 HBV 检测结果分析,探讨 HBV 宫内感染的高危因素及其预防措施。方法从陕西省人民医院产前检查中筛选254例 HBsAg 阳性孕产妇及其新生儿作为研究对象,检测两者 HBV 标志物,并同时用荧光定量 PCR 检测孕产妇血清 HBV-DNA。结果254例 HBsAg 阳性孕产妇,其新生儿脐血 HBsAg 和HBeAg 阳性率分别为5.12%和13.78%;HBeAg 阳性组孕产妇的新生儿脐血 HBV 感染阳性率53.33%,远高于 HBeAg阴性组的3.61%,差异有统计学意义(P <0.001);新生儿脐血 HBsAg 和 HBeAg 阳性率随孕产妇 HBV-DNA 含量的增加而升高,差异有统计学意义(K-W 秩和检验,P <0.001);HBeAg 阳性孕产妇的 HBV-DNA 检测阳性率100.00%,远高于HBeAg 阴性孕产妇的阳 性 率19.59%,差异有统计学意义(Fisher 确切概率法,P <0.001)。结论孕产妇 HBeAg 和HBV-DNA 阳性是新生儿 HBV 宫内感染的高危因素;对于没有实时定量检测条件的基层医院和妇幼保健院,HBeAg 筛查就尤为重要;对育龄妇女孕前进行 HBV 的干预和治疗,使 HBV-DNA 和 HBeAg 转阴后妊娠,是降低 HBV 宫内感染的有力措施。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号